Phytic acid sodium salt hydrateCAS# 14306-25-3 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
| Cas No. | 14306-25-3 | SDF | Download SDF |
| PubChem ID | 66391 | Appearance | White powder |
| Formula | C6H6Na12O24P6 | M.Wt | 923.8 |
| Type of Compound | Miscellaneous | Storage | Desiccate at -20°C |
| Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
| Chemical Name | dodecasodium;(2,3,4,5,6-pentaphosphonatooxycyclohexyl) phosphate | ||
| SMILES | C1(C(C(C(C(C1OP(=O)([O-])[O-])OP(=O)([O-])[O-])OP(=O)([O-])[O-])OP(=O)([O-])[O-])OP(=O)([O-])[O-])OP(=O)([O-])[O-].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+] | ||
| Standard InChIKey | KETSPIPODMGOEJ-UHFFFAOYSA-B | ||
| Standard InChI | InChI=1S/C6H18O24P6.12Na/c7-31(8,9)25-1-2(26-32(10,11)12)4(28-34(16,17)18)6(30-36(22,23)24)5(29-35(19,20)21)3(1)27-33(13,14)15;;;;;;;;;;;;/h1-6H,(H2,7,8,9)(H2,10,11,12)(H2,13,14,15)(H2,16,17,18)(H2,19,20,21)(H2,22,23,24);;;;;;;;;;;;/q;12*+1/p-12 | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
| Description | Phytic acid sodium salt has inhibitory effect on the activity of the digestive protease and α‐amylase in rohu, Labeo rohita, catla, Catla catla, and mrigal, Cirrhinus mrigala . The sodium salt of phytic acid may have a role in both the prevention and treatment of many forms of cancer. |
| Targets | Sodium Channel | Potassium Channel |
| In vivo | Modification of N-butyl-N-(4-hydroxybutyl)nitrosamine-initiated urinary bladder carcinogenesis in rats by phytic acid and its salts.[Pubmed: 8045454]Food Chem Toxicol. 1994 Jun;32(6):499-503.The effects of dietary phytic acid and its salts(eg. Phytic acid sodium salt hydrate) on the promotion stage of two-stage urinary bladder carcinogenesis were examined. |
Phytic acid sodium salt hydrate Dilution Calculator
Phytic acid sodium salt hydrate Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 1.0825 mL | 5.4124 mL | 10.8249 mL | 21.6497 mL | 27.0621 mL |
| 5 mM | 0.2165 mL | 1.0825 mL | 2.165 mL | 4.3299 mL | 5.4124 mL |
| 10 mM | 0.1082 mL | 0.5412 mL | 1.0825 mL | 2.165 mL | 2.7062 mL |
| 50 mM | 0.0216 mL | 0.1082 mL | 0.2165 mL | 0.433 mL | 0.5412 mL |
| 100 mM | 0.0108 mL | 0.0541 mL | 0.1082 mL | 0.2165 mL | 0.2706 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Ethyl 3,4-dicaffeoylquinate
Catalog No.:BCN8004
CAS No.:143051-73-4
- 1alpha-Hydroxy VD4
Catalog No.:BCC1300
CAS No.:143032-85-3
- ML216
Catalog No.:BCC8061
CAS No.:1430213-30-1
- Vinblastine Sulfate
Catalog No.:BCN2292
CAS No.:143-67-9
- Protoveratrine A
Catalog No.:BCN5346
CAS No.:143-57-7
- Lauric acid
Catalog No.:BCN2635
CAS No.:143-07-7
- Salvianolic acid D
Catalog No.:BCN2369
CAS No.:142998-47-8
- Salvianolic acid E
Catalog No.:BCN8194
CAS No.:142998-46-7
- Fmoc-D-Ala(3-pyridyl)-OH.HCl
Catalog No.:BCC3324
CAS No.:142994-45-4
- Fmoc-D-Phe(4-Cl)-OH
Catalog No.:BCC3177
CAS No.:142994-19-2
- UNC2025
Catalog No.:BCC8062
CAS No.:1429881-91-3
- HPOB
Catalog No.:BCC5574
CAS No.:1429651-50-2
- BQ-3020
Catalog No.:BCC5728
CAS No.:143113-45-5
- Neotuberostemonine
Catalog No.:BCN6239
CAS No.:143120-46-1
- GSK-LSD1 2HCl
Catalog No.:BCC5647
CAS No.:1431368-48-7
- BMX-IN-1
Catalog No.:BCC1434
CAS No.:1431525-23-3
- H-D-Ala-OMe.HCl
Catalog No.:BCC3199
CAS No.:14316-06-4
- UNC1999
Catalog No.:BCC4552
CAS No.:1431612-23-5
- CAL-130
Catalog No.:BCC1440
CAS No.:1431697-74-3
- CAL-130 Hydrochloride
Catalog No.:BCC1441
CAS No.:1431697-78-7
- gamma-secretase modulator 3
Catalog No.:BCC1585
CAS No.:1431697-84-5
- AT7519 trifluoroacetate
Catalog No.:BCC1377
CAS No.:1431697-85-6
- AT7867 dihydrochloride
Catalog No.:BCC1378
CAS No.:1431697-86-7
- OTSSP167
Catalog No.:BCC4314
CAS No.:1431697-89-0
Modification of N-butyl-N-(4-hydroxybutyl)nitrosamine-initiated urinary bladder carcinogenesis in rats by phytic acid and its salts.[Pubmed:8045454]
Food Chem Toxicol. 1994 Jun;32(6):499-503.
The effects of dietary phytic acid and its salts on the promotion stage of two-stage urinary bladder carcinogenesis were examined. Male F344 rats were initiated by exposure to 0.05% N-butyl-N-(4-hydroxybutyl)nitrosamine in the drinking water for 4 wk, and then treated with basal diet containing a 2% supplement of phytic acid (PA), phytic acid dodecasodium salt (Na-PA), phytic acid dodecapotassium salt (K-PA), phytic acid hexamagnesium salt n-hydrate (Mg-PA) or no added chemical for 32 wk. Na-PA significantly increased the development of preneoplastic and neoplastic lesions of the urinary bladder. K-PA also brought about a tendency for increase in papillomas, whereas Mg-PA and PA were without effect. Both Na-PA and K-PA caused elevation of urinary pH, and Na+ or K+ concentration, respectively. These results confirm the promoting activity of the sodium salt of phytic acid for urinary bladder carcinogenesis and indicate modulation by urinary components, as demonstrated by increases in urinary pH, and Na+ concentration.
